Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Cancer stem cells

  • Open Access
    ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance
    DIMITRIOS TSOUMAS, SOFIA NIKOU, EFSTATHIA GIANNOPOULOU, SPYRIDON CHAMPERIS TSANIRAS, CHAIDO SIRINIAN, IOANNIS MAROULIS, STAVROS TARAVIRAS, VASSILIKI ZOLOTA, HARALABOS P. KALOFONOS and VASILIKI BRAVOU
    Cancer Genomics & Proteomics March 2018, 15 (2) 127-141;
  • Open Access
    Chemical Proteomic Approaches Targeting Cancer Stem Cells: A Review of Current Literature
    HYE JIN JUNG
    Cancer Genomics & Proteomics September 2017, 14 (5) 315-327;
  • Open Access
    Transcriptome Analysis of CD133-positive Stem Cells and Prognostic Value of Survivin in Colorectal Cancer
    SEUNG TAE KIM, INSUK SOHN, IN-GU DO, JIRYEON JANG, SEOK HYUNG KIM, SIN HO JUNG, JOON OH PARK, YOUNG SUK PARK, AMIRALI TALASAZ, JEEYUN LEE and HEE CHEOL KIM
    Cancer Genomics & Proteomics September 2014, 11 (5) 259-266;
Cancer & Genome Proteomics

© 2023 Cancer Genomics & Proteomics

Powered by HighWire